Jin Medical International Ltd. (ZJYL)
USD 0.68
(10.37%)
USD 0.68
(10.37%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.92 Million USD | 56.46% |
| 2022 | 5.7 Million USD | -27.54% |
| 2021 | 7.87 Million USD | -21.38% |
| 2020 | 10.01 Million USD | 3.69% |
| 2019 | 9.65 Million USD | -0.22% |
| 2018 | 9.67 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 15 Million USD | 68.14% |
| 2024 Q2 | 15 Million USD | 0.0% |
| 2023 Q4 | 8.92 Million USD | 0.0% |
| 2023 Q2 | 7.47 Million USD | 0.0% |
| 2023 Q3 | 8.92 Million USD | 19.37% |
| 2023 FY | 8.92 Million USD | 56.46% |
| 2023 Q1 | 7.47 Million USD | 31.07% |
| 2022 Q2 | 6.32 Million USD | 0.0% |
| 2022 FY | 5.7 Million USD | -27.54% |
| 2022 Q4 | 5.7 Million USD | 0.0% |
| 2022 Q3 | 5.7 Million USD | -9.75% |
| 2022 Q1 | 6.32 Million USD | -19.71% |
| 2021 Q2 | 11.2 Million USD | 0.0% |
| 2021 FY | 7.87 Million USD | -21.38% |
| 2021 Q3 | 7.87 Million USD | -29.74% |
| 2021 Q1 | 11.2 Million USD | 11.9% |
| 2021 Q4 | 7.87 Million USD | 0.0% |
| 2020 Q2 | 10.24 Million USD | 0.0% |
| 2020 Q1 | 10.24 Million USD | 6.14% |
| 2020 FY | 10.01 Million USD | 3.69% |
| 2020 Q4 | 10.01 Million USD | 0.0% |
| 2020 Q3 | 10.01 Million USD | -2.31% |
| 2019 Q4 | 9.65 Million USD | 0.0% |
| 2019 Q3 | 9.65 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 9.65 Million USD | -0.22% |
| 2018 FY | 9.67 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 92.951% |
| AngioDynamics, Inc. | 112.08 Million USD | 92.038% |
| AtriCure, Inc. | 147.76 Million USD | 93.96% |
| Avinger, Inc. | 19.97 Million USD | 55.316% |
| Azenta, Inc. | 351.22 Million USD | 97.459% |
| BioLife Solutions, Inc. | 75.05 Million USD | 88.109% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.783% |
| Daxor Corporation | 858.75 Thousand USD | -939.215% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | 45.29% |
| Femasys Inc. | 9.4 Million USD | 5.093% |
| GlucoTrack, Inc. | 1.7 Million USD | -422.503% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 86.119% |
| Hologic, Inc. | 4.02 Billion USD | 99.778% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.604% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 99.563% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -10.079% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 81.742% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -1252.305% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -1252.305% |
| Masimo Corporation | 1.67 Billion USD | 99.468% |
| Microbot Medical Inc. | 3.82 Million USD | -133.255% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | 64.413% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 99.205% |
| Nephros, Inc. | 3.5 Million USD | -154.763% |
| NovoCure Limited | 783.63 Million USD | 98.861% |
| NEXGEL, Inc. | 4.78 Million USD | -86.351% |
| NEXGEL, Inc. | 4.78 Million USD | -86.351% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 89.678% |
| OraSure Technologies, Inc. | 52.17 Million USD | 82.895% |
| Pro-Dex, Inc. | 23.34 Million USD | 61.769% |
| Pulse Biosciences, Inc. | 16.44 Million USD | 45.729% |
| Predictive Oncology Inc. | 6.14 Million USD | -45.218% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -30.382% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.749% |
| Repligen Corporation | 853.2 Million USD | 98.954% |
| Sanara MedTech Inc. | 29.28 Million USD | 69.524% |
| STAAR Surgical Company | 102.73 Million USD | 91.313% |
| Sharps Technology, Inc. | 3.85 Million USD | -131.502% |
| Utah Medical Products, Inc. | 7.14 Million USD | -24.903% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.781% |